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The purpose of this study was to determine if an educational resource provided to
maternal healthcare providers, more specifically, providers in a Midwest regional hospital
and clinic, would reduce the stigma associated with maternal substance use disorder
(SUD). This project also aimed at increasing provider knowledge on the disease process
of maternal SUD and current treatment guidelines.
A quantitative research design was used for this study. There was no control
group; therefore, it is a quasi-experimental study. Qualtrics were utilized to design a pretest and post-test. An email including a brief description of the study, an invitation to
participate, and a link to the pre-test were sent to Coffeyville Regional Medical Center
Women's Health Unit and Women's Health Clinic employees. This included nurses,
obstetric gynecological physicians, a pediatrician, a family practice physician, and a
nurse practitioner. Following the pre-test, an electronic handout was provided followed
by a post-test. The pre-test and post-test results were compared to determine if the
educational handout decreased the healthcare providers' stigma associated with maternal
substance use disorder and increased their knowledge of the disease.
In conclusion, the study found that providing an educational resource decreased
provider perceived stigma and increased their overall knowledge of maternal SUD. The
study also revealed the provider's desire to become role models and a need for increased
education on maternal SUD. Providers should be encouraged to stay abreast on the topic,
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including maternal SUD evidence-based treatment guidelines, and the disease process.
Healthcare providers should also continue to evaluate personal bias related to this topic.
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CHAPTER I

Introduction

Substance Use Disorder (SUD) is a nationwide problem that includes the opioid
epidemic. On October 26, 2017, Acting Secretary of Health and Human Services Eric D.
Hargan signed a letter determining that a public health emergency exists nationwide due
to the consequences of the opioid crisis (United States Department of Health and Human
Services, 2017). From May 2017-May 2018, over 68,000 Americans died from drug
overdose (National Center for Health Statistics, 2019). Smyth et al. (2010) reported that
there was a 91% chance of relapse among those with SUD. Everyone is affected by this
disease in one way or another.
Women of childbearing age are not excluded from this epidemic. As stated by
Haight et al. (2018) “Opioid use disorder [in pregnant women] more than quadrupled
during 1999-2014 (from 1.5 per 1,000 delivery hospitalizations to 6.5)” (p. 845). Stigma
perceived both internally and externally by this population reduces compliance and
further complicates their healthcare. Studies have shown that by reducing the stigma of
this disease perceived by healthcare providers, SUD patients will have improved
healthcare outcomes.
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Description of the Problem
Maternal SUD refers to substance use during pregnancy and/or shortly after
delivery. Pregnant women with SUD are judged more harshly by family members,
healthcare providers, and the public when compared to the general population (Howard,
2015). Ober et al. (2017) reported stigma as a cause for never receiving treatment.
“Providers’ deeply held cultural beliefs and stigma commonly result in punitive
responses toward prescription opioid-dependent pregnant women” (Valez & Jansson,
2008, p. 3). Mothers are at an increased risk for adverse effects as they are not only
responsible for themselves but also for the vulnerable population of children. Many are
aware but may lack the understanding, resources, or support needed to help themselves or
others. It is a chronic, lifelong medical condition, with the likelihood of relapse.
Significance to Nursing
By educating providers on SUD and the methods to reduce the stigma, they will
be more confident and more likely to take role model positions amongst colleagues.
Cross-Sudworth et al. (2015) stated, “Confidence appears to be directly linked to
increased knowledge and training as well as ongoing support” (p. 20). Ober et al. (2017)
reported on the lack of leadership and confidence among providers in their ability to treat
SUD. There are not enough supportive providers encouraging other providers to treat
SUD. There is a lack of physician role models (Ober et al., 2017).
Reducing the stigma and thereby improving maternal health will also reduce
healthcare costs. Maternal women with opioid use disorder at the time of delivery
continue to rise. Neonatal abstinence syndrome in Medicaid-covered infants increased
more than fivefold, from 2.8 per 1000 births in 2004 to 14.4 per 1000 births in 2014

2

(Winkelman et al., 2018). As healthcare costs continue to rise, providers must be
proactive about implementing preventive measures. Encouraging an open, honest patientprovider relationship will result in increased patient compliance and improve overall
health outcomes.
Specific Aims and Purpose
The purpose of this scholarly project was to educate providers on the importance
of reducing the stigma associated with maternal SUD, more specifically, the stigma
perceived by healthcare providers in a Midwest regional hospital and clinic. This will
result in increased patient-provider trust, patient compliance, and increased positive
healthcare outcomes. Improving the mother’s overall health and state of mind will help
restore family dynamics, which will also improve the health and wellbeing of the children
that are under the mother’s care.
Increasing healthcare providers’ knowledge of SUD and the effects that stigma
has on the health of these women can better prepare them to treat this population.
Evaluation of empathy and tools to decrease the stigma, such as education, positive
thinking, and imparity, will assist providers in being more approachable, confident, and
understanding with their patients. Patients that have a trusting relationship with their
provider are more likely to follow through with treatment plans and seek additional
assistance when needed.
Theoretical Framework
The theoretical framework used to guide this project is titled “Modeling and Role
Modeling" by Helen Erickson, Evelyn Tomlin, and Mary Swain (as cited in Petiprin,
2016). This theory is about accepting the patient unconditionally, understanding how the
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patient views their environment, and modeling by healthcare providers by providing care,
acceptance, and comfort to the patient. This theory will assist healthcare providers by
helping them gain an additional understanding of the lived experiences of patients
suffering from this difficult-to-treat disease.
The main assumptions in the theory include the belief in holism, Maslow's
Hierarchy of Needs, and that all people have a drive for acceptance (Petiprin, 2016). The
assumption of holism conveys that people are more than just what they have going on;
they are individuals with a conscience. Women suffering from SUD are not simply “drug
addicts” or “users”; they are mothers and daughters that were once infants themselves.
They are like others just trying to fit in and raise their children, sometimes while
struggling with relationships and to make ends meet.
Maslow's Hierarchy of Needs is a theory that states that people require their basic
needs met before they can work on anything else. The patients may understand and agree
that they need to discontinue the substance use, but they may lack the energy or focus to
do so. They may be diverting all their attention to making sure they have a place to stay
for the night or focused on an abusive relationship. A complete family assessment is
needed to treat this population.
The assumption that people have a drive for acceptance is related specifically to
this theory, meaning people want independence and freedom. The theory implies people
do not want to be dependent; they want to be self-sufficient and able to take care of
themselves and their families. The culture demands people to be self-focused instead of
group oriented. This theory speaks of the importance of acceptance into the culture as
well as working as a group and supporting one another. The goal is to assist this

4

population to be independent while also utilizing group and community resources.
Petiprin (2016) lists the theoretical propositions utilized by this theory as the following:
an individual's ability to deal with stress related to mobilizing resources; the ability to
mobilize resources is related to their deficits, and that attachment is related to feelings of
worthiness. According to these theoretical propositions, one overwhelmed with stress
would not be capable of mobilizing resources, one without supporting resources will be at
high risk for adverse outcomes, and one that does not form attachments can suffer from
worthlessness.
By attempting to perceive the patient’s situations through their own eyes, while
simultaneously encouraging the patients to take note of their environment, the provider
will be more successful in collaborating an effective treatment plan with the patient. This
act of role modeling is theorized to enable the provider an additional understanding of the
patients’ needs to better assist them to overcome this terrible disease. By attempting to
view the patient’s situation through their own eyes, the providers will be more prepared
to recommend requests and suggestions of community resources that would work in the
patients' favor. The key variables for the model are shown in Figure 1 below.
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Figure 1
Modeling and Role Modeling to Increase Positive Outcomes of SUD

Positive SUD
Outcomes
Reduction in
Maternal
Substance Use

Holistic
Provider
Treatment

Understanding Patients

Ability to Mobilize Recourses

Accepting Patients

Drive for Acceptance

Role Modeling to Patients

Basic Needs Met

Project Questions
The questions for this project will be the following:
● What is the healthcare provider’s self-reported level of knowledge related to
maternal substance use disorder?
● What is the healthcare providers’ level of self-perceived stigma toward patients
with maternal substance use disorder before an educational intervention?
● Is there a difference in healthcare providers’ self-perceived stigma by their years
of experience in healthcare?
● Is there a difference in healthcare providers’ self-perceived stigma according to
past experiences with family or friends with substance use disorder?
● What is the healthcare providers’ level of self-perceived stigma toward patients
with maternal substance use disorder after an educational intervention?
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● Does the healthcare provider plan to change their views of maternal substance use
disorder after the educational intervention?
● What are the healthcare providers’ intentions toward role modeling regarding the
treatment of maternal substance use disorder after the educational intervention?
Definition of Key Terms
These definitions will be the focus of this project:
Empathy- De Waal et al. (as cited in Segal & Wagaman, 2017) described
empathy as “the bond that connects people on individual levels, facilitates social
agreements, and promotes democratic decision making” (p. 204). Segal and Wagaman
(2017) described empathy as “the ability to understand the behaviors of others and the
meanings of those behaviors” (p. 204).
Healthcare provider- Bricker & Eckler (n.d.) described a healthcare provider as
“a provider of medical or health services and any other person or organization who
furnishes, bills, or is paid for health care in the normal course of business” (para. 1).
Examples of this would include doctors, nurses, nurse practitioners, and certified nurse
aids.
Maternal- is defined as an adjective meaning “relating to a mother, especially
during pregnancy or shortly after childbirth” (Lexico, n.d., para. 1).
Stigma- Goffman (as cited in Howard, 2015) described stigma as a social
construction involving negative differences that devalue and dehumanize a person.
Howard (2015) stated “the shame one experiences from being stigmatized necessitates
some way to manage perceptions of both internal and external stigma” (p. 422). These
meanings will be focused on for this project.
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Substance Use Disorder- substance use disorder (SUD) is defined as “when a
person's use of alcohol or another substance (drug) leads to health issues or problems at
work, school, or home” (MedlinePlus, 2019, para.1). The general term ‘drug’ is defined
as “any substance, stimulating or depressing, that can be habituating or addictive,
especially a narcotic” (American Heritage Publishing Company, n.d., para. 1).
Logic Model
The logic model for this project was designed using inputs, outputs, assumptions,
and external factors. A visual of the map can be seen in Figure 2 below. An ample
amount of time will be required to do research, plan the project, and implement the
teaching intervention. Computers will be utilized to store, design, and provide surveys
and electronic handouts. The facility email and computers will be needed to implement
the surveys and teaching intervention. Funding will not be needed for this project.
Assumptions include a window of opportunity, healthcare provider truthfulness,
and the readiness to change. External factors include provider bias, the rural area, and
access to the survey. As stated previously in this paper, there is currently an opioid
epidemic that presents a chance for teaching the reduced stigma intervention to providers.
Pregnant women expect to be questioned at prenatal visits about their social life and
health; this, according to Cross-Sudworth et al. (2015), creates a “window of
opportunity.” This project is taking place in a rural area where “everyone knows
everyone”; the providers will be encouraged to be truthful on the surveys. They will be
reminded that the surveys are for learning purposes only and will be confidential
including no names or tracking methods. The final assumption made for this project
includes the perception of change regarding the providers and the patients. The providers
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will be advised to do a self-evaluation regarding their social issues, which may hinder
their relationships with this population. The patients are assumed to be perceptive to
change during this time in their lives where there is a change in family dynamics.
The outcomes of the project (Figure 3 below) include short-term, intermediate,
and long-term goals. The short-term goals lead to long-term goals, which include
increased provider awareness of SUD stigma, increased patient compliance, and
provider-patient trust, which will result in provider role models of reducing SUD stigma,
reduced neonatal abstinence syndrome, and reduced number of children entering publicprovided care. Increased awareness of self-needs will result in increased awareness of
self-worth and increased family dynamics.
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Figure 2
Reducing the Stigma Associated with Maternal SUD
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Table 1
Study Outcomes
OUTCOMES
Short-term

Intermediate

Long-term

Increased Provider
Awareness of SUD Stigma

Reduced Provider
Perceived Stigma

Provider Role Models of
Reducing SUD Stigma

Increased Patient
Compliance

Reduced Positive Drug
Screens

Reduced Neonatal
Abstinence Syndrome

Increased Patient-Provider
Trust.

Increased Enrollment in
Community Services

Reduced Number of
Children Entering into
Public Provided Care

Increased Self-Awareness
of Needs

Increased Awareness of
Self Worth

Increased Family
Dynamics
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Summary
Maternal substance use disorder (SUD) is an ongoing chronic disease that affects
all families and communities. Rural communities are at an additional disadvantage with
limited resources, increased stigma, and fewer outreach programs. Families are often
pulled between supporting their family members and seeking additional resources for
help, and often feel judged themselves while doing so.
By reducing the stigma associated with maternal SUD beginning with health care
providers, these patients will be more apt to seek help, be compliant with the treatment
plan, and have positive outcomes. It is hypothesized that by improving the health of this
population, the family dynamics will also improve, thereby reducing the risk factor of
future generations sharing the same disease. A teaching intervention aimed at reducing
the stigma associated with SUD, implemented to maternal health care providers, will
assist with this goal.
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CHAPTER II

Literature Review

The current literature was reviewed to gain a better understanding of the stigma
associated with maternal SUD and the methods to reduce it. Relevant articles were
obtained from the PubMed database and the Cumulative Index to Nursing and Allied
Health Literature (CINAHL). Search phrases included maternal substance use disorder,
provider perceptions, provider education, health-related stigma, and methods to reduce it,
SUD noncompliance, and the “window of opportunity.” Articles were limited to the peerreviewed, English language, and published within the last seven years. Two benchmark
articles were also utilized. The search produced thirty-two relevant articles. Examination
of the articles revealed the following themes: Maternal SUD barriers to treatment,
provider barriers to treatment, opportunities for treatment of Maternal SUD, the benefits
of reducing the stigma surrounding maternal SUD, and the methods to reduce the stigma
and educate providers.
Maternal SUD Barriers to Treatment
When treatment is not utilized, barriers, or reasons for not utilizing the treatment
are researched. Barriers to healthcare can include physical, mental, and/or financial
reasons. Once these barriers are identified, methods to overcome them can be
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implemented to increase the utilization of treatments. Maternal SUD barriers found in the
research included stigma, lack of resources, and judicial involvement.
Stigma
There are many different factors related to maternal SUD stigma, including
causing agents and effects. Stigmas can be internal and/or external. They can be
perceived by family members, the community, or providers. Fragassi and Bora (2018)
found that the under-reporting of maternal SUD is thought to be caused by the fears of
social stigmatization. Stigma has continued even though there is now a better
understanding of SUD and the disease process (Fragassi & Bora, 2018). Van Scoyoc et
al. (2016) stated “stigmas include the belief that individuals with addiction are not
capable of making decisions” (p. 77). This can reduce a patient’s autonomy and leave
them fighting for control.
Stringer and Baker (2018) found that “mothers experience the most stigma
compared with father, nonmothers, or nonfathers” (p. 16). This can result in mothers
being more defensive and less likely to seek resources for themselves and their children.
Stigma (related to treatment from providers) due to their beliefs and bias from society
was found to induce internal stigma from shame (Howard, 2015). Walter et al. (2017)
discussed the importance of “countering stigmatization and fostering compassion” (p.
1714). Wigg et al. (2017) stated “social connection with others were described as
challenging for some mothers because of negative and traumatic childhood experiences”
and that they “don’t have the confidence in people” (p. 1249). Cockroft et al. (2019)
found an overall distrust in the healthcare system due to stigma and in part due to the
healthcare’s role in prescribing the opioids that some patients have become dependent on.
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Resources
Traube et al. (2015) reported on the need for childcare support to increase
compliance with treatment. Mothers are not able to make appointments due to having
unreliable supervision for their children and/or a lack of transportation. Wigg et al.
(2017) stated substance-dependent women with substance abuse in their family not only
“needed support to stay abstinent” but also “needed to distance themselves from their
social network and family” (p. 1247). This provides a whole new and unfamiliar world
for the women. By better understanding the needs of support for this population,
providers will be more successful in implementing the help and safety needed to achieve
health goals (Wigg et al., 2017). Participants in Wigg et al. (2017) stated feelings of
“growing together with my child” when being discharged with their child following
successful treatment (p. 1249).
Fragassi and Bora (2018) stated that many women with SUD experience
homelessness. Now is not the time to turn a blind eye. Ignoring the problem will not
make it better. Communities must work together to support this vulnerable population.
Sahker et al. (2015) found from their research that most pregnant SUD patients seek
treatment, not from self-referral but other social support groups, including religious
organizations, government agencies, recovery groups, and social welfare agencies.
Gopman (2014) reports on the bravery of women with maternal SUD to seek
treatment, possibly due to their neglected childhoods. Gopman (2014) lists this as being
one of the first steps to “improving their health and investing in the health of their
children and families” (p. 221).
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Milligan et al. (2016) revealed that women reported being able to “break down
emotional barriers, take emotional risks and begin to build trust in the relationship” (p.
257). Women reported the counselors adapted treatment to meet their cognitive and
learning needs, through addressing risk factors, providing cues, and helping women
internalize these skills (Milligan et al., 2016). These findings will be utilized to encourage
social support recommendations by maternal health care providers.
Judicial Involvement
Women can be reluctant to disclose social circumstances and hide SUD from their
providers to avoid losing parental rights. Study participants referred to “the therapeutic
path to failure” to describe the results of the punitive measures used by treatment centers
(Mora-Rios et al., 2017, p. 602). The research has found that by reducing the threats and
reputation of automatically severing parental rights, women will be more likely to have
an open, honest relationship with their providers. A collaborative approach to treatment
without criminal sanctions is the best way to help this population (Committee on
Obstetric Practice, 2017).
Providers have an obligation to advocate for their patients and encourage longterm follow-up and “discourage the separation of parents from their children”
(Committee on Obstetric Practice, 2017, p.11). Research has shown that by keeping the
dyad together during treatment, the development of the infant, as well as the recovery of
the mother, can be beneficial (Suchman & DeCoste, 2018). Van Scoyoc et al. (2016)
found that women want to seek treatment but ultimately “take matters into their own
hands” to avoid child welfare involvement or the justice system (p. 76). This becomes a
barrier to care and delays treatment.
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Provider Barriers to Treatment
Providers can encounter barriers to implementing healthcare. These barriers can
include availability, understanding, and interpretation. The research found time, the
complexity of the disease, lack of education, and lack of role models/confidence as
barriers to treatment by providers.
Time
The research found repeated reports of time being the reason patients were not
questioned and directed about SUD. Providers did not feel they had adequate time to
establish the right environment and mood for the personal discussion about social
behaviors. Cross-Sudworth et al. (2015) found the report of not enough time and quoted
providers as “generally, not enough time allocated for appointments as consultations
invariably take longer…. Need more time to enable a more thorough and satisfying
consultation for women and midwives” (p. 17). Howard (2015) discussed the lack of time
to assist opioid-dependent pregnant women and how prenatal social workers can provide
ongoing mutual support to this population. One study revealed that women felt written
material was given in place of spending time with them (Ebert et al., 2014). The same
study also found that during verbal communication, patients were not given the time to
ask questions (Ebert et al., 2014).
Complexity of Disease
Maternal SUD is a complex disease in which the practitioner is not only
responsible for one life but two, requiring a multidisciplinary approach. Gopman (2014)
reports on the difficulty screening for maternal SUD. Mandated urine drug screens often
miss sporadic drug use (Gopman, 2014). Women will wait for negative UA results before
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scheduling prenatal appointments or skip them all together. Due to fears, women may not
seek treatment until pregnancy complications occur or late into the pregnancy (Gopman,
2014).
The disease can be co-occurring with mental illness and/or trauma and followed
by non-compliance (Lee King et al., 2014). This can leave obstetricians reluctant to treat.
However, Pitt et al. (2018) report on the complexity of the disease with high relapse and
recurrence rates. This complex disorder calls for an increase in social support; be it from
health care facilities, family members, social network groups, church groups, or courtmandated meetings, the evidence is substantial that support is necessary for success.
Lack of Education
The research found a lack of provider education as a barrier to addressing and
treating maternal SUD. More training is needed to understand addiction, improve
evidence-based treatment, and chronic pain and opioid prescribing. Press et al. (2016)
found that patients need their providers to understand their addiction. When providers are
educated on the disease, they are more comfortable with addressing the medical and
physiologic aspects of the disease (Press et al., 2016).
Williams et al. (2020) found that provider education should focus on uniformity,
including evidence-based treatment for maternal SUD. It is well known that evidencebased treatment improves prevention, treatment, and recovery. There is a
misunderstanding of the pharmacotherapy and indications for drug testing in this
population (Williams et al., 2020). Cushman et al. (2017) found that providers want to
know how to safely prescribe alternatives to opioids. Providers were found to be torn
between treating their patients and specific government regulations (Cushman et al.,
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2017). Lee King et al. (2015) reported the need for clear and simple information
including protocols to improve treatment. Providers are less confident and less likely to
treat maternal SUD when they are lacking the required training to address this population.
Lack of Role Models/Confidence
Critchfield et al. (2018) stated, “Ob/gyns are on the front lines of this epidemic
and have a responsibility to recognize, treat, refer and advocate for the pregnant women
with opioid use disorder” (p. 10). These providers can make a difference and be role
models for their colleagues to help combat this epidemic. Mora-Rios et al. (2017) wrote
on the stigma related to medical staff as being due to the lack of interest and commitment
towards addiction, as well as the “failure of health care personnel to deal with their own
emotional problems” (p. 598). This results in a lack of provider role models and leaders
in the treatment of SUD. Mora-Rios et al. (2017) reported on common practices of lack
of administrative support, including from the bureaucracy, as well as the stigma received
by coworkers for working with this population.
Opportunities for Treatment of Maternal SUD
“See a need, fill a need.” These “needs” in healthcare are referred to as
opportunities. When opportunities are recognized, they can be acted upon to implement
treatments. Opportunities for treatment found in the research included the regularly
scheduled appointments referred to as the ‘window of opportunity’ and the trusting
relationship developed between the providers and patients.
Regularly Scheduled Appointments/ ‘Window of Opportunity’
Lee King et al. (2015) wrote about the “critical window of opportunity for longterm impact” regarding the needs of pregnant patients with high risks (p. 180). Women in

18

their childbearing age might be experiencing access to healthcare for the first time since
childhood. Studies have also shown an increased interest in their own health and
motivation to change during this time of their lives. Pregnant women expect to be
questioned at prenatal visits about their social life and health; this, according to CrossSudworth et al. (2015), creates a ‘window of opportunity’. Pregnancy often serves as an
opportunity for women to engage in healthy change (Gopman, 2014). Gopman (2014)
stated, “Given the incidence of substance abuse in pregnancy, all clinicians who provide
prenatal care encounters affected women” (p. 214). These providers have an opportunity
to impact not only the women’s lives but also the family unit. Obstetric providers present
a unique setting to SUD due to the co-occurring illnesses found with SUD. Providers can
recognize SUD in patients that come in for regular prenatal visits. They also are
prescheduled and are more likely to establish a trusting relationship with the patient.
Trusting Relationship with Patients
Pregnant patients spend a lot of time with their providers and the office staff. In
an uncomplicated pregnancy, this amounts to at least one visit every four weeks until the
28th week, at which time the visits are increased to every two weeks and then weekly
after 36 weeks gestation (Carter et al., 2016). This time allows for the patient-provider
relationship to grow and bonds of trust to be formed. Sword et al. (2012) found that this
increased trust among patients and providers was an essential part of quality care. It was
also found that this increased trust, promoted a woman's involvement in self-care, as well
as helped mitigate any adverse outcomes (Sword et al., 2012).
Bonds are commonly formed with maternal patients and their providers. Kao et al.
(1998) found that the more time a patient spends with their provider the more of a
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trusting relationship they will have. The patients with a choice of provider also increased
their trust in the healthcare organization (Kao et al.,1998). This increased trust formed
between patients and providers will promote open communication, which then allows for
the increased opportunity of treatment for SUD.
Benefits of Reducing the Stigma Surrounding Maternal SUD
Positive interventions can result in desired outcomes or healthcare benefits. These
benefits can include patients utilizing treatment, healthcare prevention, and healthcare
maintenance. The benefits of reducing the stigma surrounding maternal SUD were found
to be increased SUD treatment, increased compliance with the healthcare plan, and
increased positive healthcare outcomes including reduced emergent visits.
Increased SUD Treatment
The literature found that by reducing the stigma surrounding maternal SUD,
patients were more likely to be open and honest about their disease. This would then
provide an opportunity for the provider to address the disease and develop a treatment
plan with the patient. When maternal SUD is understood as a disease, and stigma is not
attached to it, providers can then implement screenings for substance use.
Increased Patient Compliance
It is well known that collaborating the healthcare plan with the patient increases
patient compliance. Stone (2017) found that “incorporating women’s voices” regarding
their perceived barriers to healthcare related to maternal SUD will increase their
likelihood of compliance (p. 14).
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Increased Positive Outcomes with Reduced Emergent Visits
Reducing the maternal SUD stigma resulted in increased positive healthcare
outcomes. Kotelcuch et al. (2017) found a specific association between the treatment of
SUD and a lower risk of adverse birth outcomes. Mothers in treatment plans for SUD
were less likely to have placental abruptions, drug overdoses, and fetal demise
(Staszewski, 2019). These mothers were also more likely to receive prenatal care in
general if they were receiving treatment for SUD. Infants diagnosed with neonatal
abstinence syndrome had shorter hospital stays on average when compared to infants
born to mothers that were not receiving treatment for SUD (Staszewski, 2019).
Methods to Reduce the Stigma and Educate Providers
Tools can be utilized to improve healthcare. These tools or methods, once
identified, can then be studied, and taught to providers to increase patient healthcare
outcomes. The literature review revealed that stigma related to maternal SUD could be
reduced by utilizing methods of empathy, proper communication, increased education,
and policy change.
Empathy
Empathy is a vital component in providing up-close, personal, holistic patient
care. Moralle et al. (2016) researched the level of empathy expressed by resident
physicians and found that the level of empathy decreased during long shifts and stints of
work without vacation. This information can be utilized to encourage physician self-care
and time off to increase levels of empathy towards their patients. Smith et al. (2017)
found that empathy could improve with training. Empathy scales can also be utilized to
better understand areas that need a change in the medical practice (Smith et al., 2017).
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Communication
Stone (2017) found that “better communication between medical staff and
mothers may help ease confusion and feelings of stigmatization and unfair treatment” (p.
13). Mothers reported not knowing that their newborns would have such serious
withdrawal symptoms and that child protective services would be involved (Stone, 2017).
Using medically correct terminology decreases the stigma associated with
maternal SUD. Avoiding words like an addict, user, clean, and dirty and instead of using
medically nonnegative words like abstinence, a person with a SUD, and simple clear-cut
words like negative and positive were better accepted and more appropriately in line with
the terminology used to describe other chronic diseases (U.S. Department of Health and
Human Services Health Resources and Services Administration, 2020).
Education
Vendetti et al. (2017) found that increased education and attention to barriers in
the implication of the screening, brief intervention, and referral to treatment (SBIRT)
were needed to be successful in addressing SUD. Vendetti et al. (2017) found education
was lacking in communication, collaboration, and leader support for the implementation
of the SBIRT. Milligan et al. (2016) found that administrators and policymakers needed
more training on the emotion regulation and executive functions related to women with
substance-related problems.
Howard (2015) found that healthcare providers need more training to understand
that mothers should be encouraged to parent their children and be reminded that they do
have the capabilities and resources available to assist them. Healthcare providers should
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be educated on the complexity of maternal SUD and strategies to reduce the stigma
(Howard, 2015).
Policy Changes
Kotelcuch et al. (2017) found a lack of services for women with SUD. This
finding should “reinforce policy makers’ efforts to invest in treatment programs for
women with SUD'' (p. 901). Stone (2015) found that punitive policies have discouraged
women from seeking prenatal care or skipping their appointments and withholding
medically relevant information.
Policy change is needed to encourage newborns to room in with their mothers
when appropriate (Committee on Obstetric Practice, 2017). Neonatal abstinence
syndrome symptoms were reduced, and improved infant/maternal bonding development
was noted with the encouragement of breastfeeding in this population (Committee on
Obstetric Practice, 2017).
Summary and Future Direction
Studies have increased over the past few years, with more maternal SUD research
being done now than ever before. Now is the time to address this epidemic and
implement practice changes. Maternal SUD is a chronic, lifelong, treatable disease with
several ways to reduce barriers and increase the opportunities for treatment. Maternal
healthcare providers are on the frontlines treating a population that may not always want
to seek treatment or have the resources available to receive treatment. This population
shows courage, to be honest about their fears and be willing to trust health care providers.
Maternal providers have a duty to seek education to provide evidence-based treatment.
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This includes incorporating the neuropathology of SUD into their practice by reducing
the negative terminology and using medically correct terms to describe the disease.
Increasing the knowledge of maternal SUD to maternal healthcare providers is a
way to increase trust and compliance. Increasing trust and compliance with this
population will result in fewer adverse health outcomes and emergent visits, which will
decrease overall healthcare costs and improve overall family dynamics. This intervention
has the potential to do the most good with the least amount of cost to society.
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CHAPTER III

Methodology

Project Design
A pre-test/post-test research design was used for this study. There was no control
group; therefore, it is a quasi-experimental study. Qualtrics were utilized to design a pretest and post-test. An email including a brief description of the study, an invitation to
participate, and a link to the pre-test were sent to Coffeyville Regional Medical Center
Women's Health Unit, Coffeyville Women's Health Clinic, and Coffeyville Regional
Medical Center Family Practice Pediatrics employees. This included registered nurses,
obstetric gynecological physicians, a pediatrician, a family practice physician, and a
nurse practitioner. Following the pre-test, an electronic educational handout was provided
followed by a post-test. The pre-test and post-test results were compared to determine if
the educational handout decreased the healthcare providers' stigma associated with
maternal substance use disorder and increased their knowledge of the disease. Objective
data was examined statistically to answer the project questions:
● What is the healthcare provider’s self-reported level of knowledge related to
maternal substance use disorder?
● What is the healthcare providers’ level of self-perceived stigma toward patients
with maternal substance use disorder before an educational intervention?
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● Is there a difference in healthcare providers’ self-perceived stigma by their years
of experience in healthcare?
● Is there a difference in healthcare providers’ self-perceived stigma according to
past experiences with family or friends with substance use disorder?
● What is the healthcare providers’ level of self-perceived stigma toward patients
with maternal substance use disorder after an educational intervention?
● Does the healthcare provider plan to change their views of maternal substance use
disorder after the educational intervention?
● What are the healthcare providers’ intentions toward role modeling regarding the
treatment of maternal substance use disorder after the educational intervention?
Data obtained from this study will be utilized to direct future studies. A project design is
depicted in Figure 3.
Figure 3
Project Design
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Target Population
The target population for this project included health care providers with direct
contact with maternal SUD patients in a rural community health setting. This included
nurses, obstetric gynecological physicians, a pediatrician, a primary care physician, and a
nurse practitioner.
Target Population Recruitment
The target population was recruited using convenience sampling. A mass email
was sent to Coffeyville Regional Medical Center Women's Health Unit, Coffeyville
Women's Health Clinic, and Coffeyville Regional Medical Center Family Practice
Pediatrics employees inviting them to participate in the study. Respondents meeting the
inclusion criteria were included in the study. No compensation was given to participants.
Inclusion and Exclusion Criteria
Inclusion criteria included current employees of Coffeyville Regional Medical
Center Women's Health Unit, Women's Health Clinic, and Family Practice Pediatrics
with a working email address and direct patient contact of maternal SUD patients. This
included nurses, obstetric gynecological physicians, a pediatrician, a family practice
physician, and a nurse practitioner.
Exclusion criteria were those that are not employed at Coffeyville Regional
Medical Center Women's Health Unit, Women's Health Clinic, or Family Practice
Pediatrics and do not have a working email. Those that do not have direct contact with
maternal SUD patients were also excluded.
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Protection of Human Subjects
Patient information was not accessed or utilized for this study. Information
obtained from the study was kept confidential and electronic. This project is exempt;
therefore, informed consent was assumed by the participants participating in the project
by filling out the surveys and reviewing the educational handout.
The principal investigator and the DNP scholarly project committee (Mandi
Alonzo, Kristi Stuck, and Gena Coomes) had access to the data during the study. The
data will be stored on the faculty advisor's password-protected computer for two years
after the completion of the project. The faculty advisor was the only one with access to
the data after the project.
Names were not used for this study. Participation in the study was voluntary. The
information gained in the study did not affect employment. An IRB form was submitted
to the review board of the Irene Ransom Bradley School of Nursing at Pittsburg State
University. Permission for the study and access to the email system was obtained from
the Coffeyville Regional Medical Center education coordinator and director of quality
and risk management as instructed by the chief nursing officer.
Directors at the three cooperating facilities were given a copy of the final project
report. The results of the research were posted in the break room of the Coffeyville
Regional Medical Center Women's Health Unit, Coffeyville Women's Health Clinic, and
Coffeyville Regional Medical Center Family Practice Pediatrics.
Instruments
This study included the use of three instruments: the pre-test (See Appendix A),
post-test (See Appendix B), an educational handout (See Appendix C). No previous
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instruments were found specific to this study; therefore, these were created. The created
surveys were validated by peer review including OB/GYN addiction expert, Dr. Mishka
Terplan, Pittsburg State University Assistant Professor/ Master Advisor Dr. Kristi Stuck,
and Pittsburg State University Instructor/Master Advisor Dr. Amanda Alonzo. The pretest contained three demographic questions and 14 questions related to the awareness of
maternal SUD, the self-perceived stigma associated with maternal SUD, and the clinical
practice related to maternal SUD. The educational handout included background
information, statistics, evidence-based guidelines, and charts that were easy to understand
and remember. The post-test contained 14 questions related to the awareness of maternal
SUD, the self-perceived stigma associated with maternal SUD, and the clinical practice
related to maternal SUD. There were no financial costs for the instruments utilized for
this study.
Procedure
To review for any risks to study participants, Institutional Review Board (IRB)
approval was obtained before the start of this study. Once the study was approved, the
target population was contacted via email requesting participation. Participants were
emailed instructions and links to the pre-test, educational handout, and post-test.
The study began with the pre-test. Following the completion of the pre-test,
participants were directed to an educational handout. The educational handout was
created by this author utilizing the information gained from the extensive literature
review of maternal substance use disorder. Interventions and guidelines found in the
literature to reduce the stigma associated with maternal SUD were included in the
educational handout. The educational handout also included statistical information
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regarding SUD and methods to increase patient/provider trust, compliance, and positive
healthcare outcomes.
Following the educational handout, participants were directed to the post-test.
The post-test was like the pre-test but excluded demographic questions and included
questions regarding plans for practice change.
Evaluation Methods
Data was gathered in a Qualtrics statistical program. The data from Qualtrics was
uploaded onto the researchers’ computer and was compared using Excel for the pre-test
and post-test questions. Paired t-tests were conducted to evaluate correlation and
significance. The principal investigator and the DNP Scholarly Project Committee
(Mandi Alonzo, Kristi Stuck, and Gena Coomes) had access to the data during the study
and assisted with the interpretation. Every effort was made to maintain anonymity.
Identifiers were not utilized during this study. The study material was only accessed on
the researcher's locked and password-protected laptop computer. The outcomes were
assessed for correlations between education and stigma reduction towards patients.
Plan for Sustainability
The stigma associated with maternal SUD has been well documented as a barrier
to treatment (Howard, 2015). The goal of this study was not only to reduce the provider
perceived stigma but also to encourage provider role models among colleagues. Lack of
provider role models has been determined to be a cause of reduced substance use disorder
treatment (Ober et al., 2017).

30

Summary
This study was designed using a pre-test/post-test research method to gain a better
understanding of healthcare providers' self-reported stigma related to maternal SUD. The
target population included those with valid medical licensure in a rural Midwest setting
who had direct contact with maternal SUD patients. An electronic educational handout
was designed to increase healthcare providers' knowledge and understanding of maternal
SUD treatment and methods to reduce the perceived stigma. The results of the study can
be utilized to assist in future studies involving educating providers and evaluating the
effectiveness of teaching methods.
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CHAPTER IV

Results

This project was developed with the goal of reducing the stigma associated with
maternal substance use disorder. By reducing the stigma, specifically stigma perceived by
healthcare providers, patients would be more likely to seek prenatal care and be
compliant with their plan of care. The objective questions addressed in the survey
examined maternal health care providers’ self-reported knowledge and stigma related to
maternal substance use disorder (SUD). Participants completed a self-report survey
regarding their knowledge of and stigma related to maternal SUD. They were then given
an educational resource on maternal SUD treatment guidelines, the effects of stigma, and
ways to reduce the stigma. Participants then completed a post-self-report survey. The
purpose was to determine if an educational resource would reduce the stigma associated
with maternal SUD.
Description of the Population
Coffeyville Regional Medical Center Women's Health Unit and Women's Health
Clinic employees were invited to participate in the study. This included nurses, obstetric
gynecological physicians, a pediatrician, a family practice physician, and a nurse
practitioner. A total of 23 healthcare providers meeting the inclusion criteria were invited
to participate. Of those 23, 14 participates completed the pre- and post-surveys and two
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participants completed just the pre-survey. The participates were invited utilizing email
and were directed to Qualtrics.com where the pre-test, educational resource, and post-test
were conducted. The survey ran from August 16th, 2021, to August 30th, 2021.
Participants were only asked to report their demographics on the pre-test. The
demographic information collected included practice type, years of experience, and
whether the respondents had a family member or close friend with SUD.
Fourteen respondents were registered nurses (87.5%), and two respondents were
obstetric gynecological physicians (12.5%) (Figure 4). There were no reports of
pediatricians, family practice physicians, or nurse practitioners.
Figure 4
Profession of respondents

The majority (75%) of the respondents had over 10 years of experience (Figure
5). Two (12.5%) of the respondents had less than 1 year of experience. One (6.25%)
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respondent reported between 2-5 years of experience and one (6.25%) respondent
reported between 6-10 years of experience.
Figure 5
Years of experience of respondents

The respondents were almost evenly divided between if they did or did not have a
family member or close friend with substance use disorder (Figure 6). Nine respondents
(56.25%) reported that they did not have a family member or close friend with substance
use disorder and seven (43.75%) reported that they did have a family member or close
friend with substance use disorder.
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Figure 6
Report of a family member or close friend to someone with substance use disorder

Key Variables
Independent Variable
For this study, the independent variable was the educational resource. The
resource was designed by this researcher based on evidence-based research. It was then
reviewed by OB/GYN addiction expert, Dr. Mishka Terplan. The resource was provided
to participants as an electronic two-page handout. Participants were able to view the
resource at their own pace and could download it for future reference.
Dependent Variable
The dependent variables were the providers’ self-reported level of knowledge
associated with maternal substance use disorder (7 questions), providers’ self-perceived
stigma (3 questions), and providers’ current practice (4 questions). The three dependent
variables were affected by education. The self-reported awareness was increased. The
self-reported stigma was decreased, and current practice change was reported.
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Analyses of Project Questions
Data was collected via the pre-test and post-test. The pre-test and post-test data
were then compared and analyzed using Qualtrics and Excel. Paired t-tests were
conducted to evaluate correlation and significance. This data was then utilized to answer
the seven project questions.
Question One: What is the healthcare provider’s self-reported level of knowledge
related to maternal substance use disorder?
This question was answered using questions 1-7 on the pre-test and post-test.
Questions 1-4 were answered using a 1-10 scale with 10 being the most amount and 1
being the least amount (Figure 7). Questions 5-7 were answered using a 1-10 scale with
10 strongly agreeing and 1 being strongly disagreed (Figure 8). The questions were
identical on both the pre and post-tests.
Figure 7
Self-reported provider awareness associated with maternal substance use disorder from
least amount to the most amount.
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LEGEND
Q1 How much do you know about Maternal Substance Use Disorder?
Q2 How much do you know about the perceived stigma associated with
Maternal Substance Use Disorder?
Q3 How would you rate your level of confidence in communicating with
people with substance use disorder?
Q4 How important are role models to patients with Maternal Substance Use
Disorder?
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Figure 8
Self-reported provider awareness associated with maternal substance use disorder from
strongly disagree to strongly agree.
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Q5 Those with Substance Use Disorder are to blame for the problem.
Q6 Those with Substance Use Disorder are responsible for their own health.
Q7 Substance Use Disorder is a treatable chronic disease.

Respondents self-reported more knowledge after the educational resource on
maternal SUD and the perceived stigma related to maternal SUD. They also self-reported
more confidence in communicating with SUD patients, and a better understanding of the
importance of role models for maternal SUD patients. Significant correlations related to
understanding the disease process following the educational resource included the
importance of role models (r = .58, p = .020), not blaming patients for their disease (r =
.55, p = .029), SUD is a treatable chronic disease (r = .64, p = .008).
Question Two: What is the healthcare providers’ level of self-perceived stigma
toward patients with maternal substance use disorder before an educational
intervention?
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This question was answered using questions 8-10 on the pre-test. Questions 8 & 9
were answered using a 1-10 scale with 10 being the most amount and 1 being the least
amount (Figure 9). Question 10 was answered using a 1-10 scale with 10 strongly
agreeing and 1 being strongly disagreed (Figure 10).
Figure 9
Self-reported provider perceived stigma
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Q8 How would you rate your personal stigma related to Maternal Substance Use Disorder
patients?
Q9 Do you feel you treat Maternal Substance Use Disorder patients differently?
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Figure 10
Self-reported perceived stigma as a health determinant for maternal substance use
disorder
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Q10 Stigma is a health determinant for people with Maternal Substance Use Disorder.

On a scale of 1-10 with 1 being the least amount and 10 being the most amount,
respondents self-reported a 5.06 on the level of personal stigma related to maternal SUD
patients, and a 4.06 on the level of treating maternal SUD patients differently before the
educational resource. The respondents reported a 6.19 with 1 being strongly disagreed
and 10 strongly agreeing on the level of stigma being a health determinant for people
with maternal SUD.
Question Three: Is there a difference in healthcare providers’ self-perceived stigma
by their years of experience in healthcare?
This question was answered by comparing the answer to question 2 in
demographics to the answers to questions 8-10 on the pre-test (Figure 11). Question 2
was multiple choice with option A. being 0-1 years, option B. 2-5 years, option C. 6-10
years, option D. 10+ years, and option E. Would Rather Not Say. Questions 8 & 9 were
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answered using a 1-10 scale with 10 being the most amount and 1 being the least amount.
Question 10 was answered using a 1-10 scale with 10 strongly agreeing and 1 being
strongly disagreed.
Figure 11
The self-reported difference in health providers’ level of stigma compared to years of
experience
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Q8 How would you rate your personal stigma related to Maternal Substance Use Disorder patients?
Q9 Do you feel you treat Maternal Substance Use Disorder patients differently?
Q10 Stigma is a health determinant for people with Maternal Substance Use Disorder.

According to the data, there appears to be a curve in self-reported stigma related
to maternal SUD patients, with the least amount of self-reported stigma being between
the 2-10 years of practice experience and the most amount of self-reported stigma at the
beginning of practice and after 10 years of experience. A similar curve is also seen in the
self-reporting of treatment of maternal SUD patients. The data shows that the new
providers and those with over 10 years of experience are most likely to treat patients with
maternal SUD differently.
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Question Four: Is there a difference in healthcare providers’ self-perceived stigma
according to past experiences with family or friends with substance use disorder?
This question was answered by comparing the answer to question 3 in demographics
to the answers to questions 8-10 on the pre-test (Figure 12). Question 3 was multiple
choice with option A. being “YES”, B. “NO” and C. “Would Rather Not Say”. Questions
8 & 9 were answered using a 1-10 scale with 10 being the most amount and 1 being the
least amount. Question 10 was answered using a 1-10 scale with 10 strongly agreeing and
1 being strongly disagreed.
Figure 12
Self-reported stigma related to past experiences with family or friends with SUD
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Q3 in demographics, Do you have a family member or close friend with Substance Use Disorder?
Q8 How would you rate your personal stigma related to Maternal Substance Use Disorder patients?
Q9 Do you feel you treat Maternal Substance Use Disorder patients differently?
Q10 Stigma is a health determinant for people with Maternal Substance Use Disorder.

The survey results indicated that the providers with previous experience of
a family member or friend with SUD, self-reported increased stigma related to maternal
SUD patients (5.2/10 compared to 4.8/10). These providers also reported a higher amount
regarding treating maternal SUD patients differently (4.5/10 compared to 3.6/10).
Following the educational resource there was a better understanding of the treatment of
maternal SUD patients (r = .70, p = .003). Providers with experience of a family member
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or friend with SUD also were less likely to agree that stigma is a health determinant for
people with maternal SUD (5.7/10 compared to 6.5/10).
Question Five: What is the healthcare providers’ level of self-perceived stigma
toward patients with maternal substance use disorder after an educational
intervention?
This question was answered using questions 8-10 on the post-test. Questions 8 & 9
were answered using a 1-10 scale with 10 being the most amount and 1 being the least
amount (Figure 13). Question 10 was answered using a 1-10 scale with 10 strongly
agreeing and 1 being strongly disagreed (Figure 14).
Figure 13
Self-reported provider perceived stigma after educational intervention
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Figure 14
Self-reported perceived stigma as a health determinant for Maternal Substance Use
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On a scale of 1-10 with 1 being the least amount and 10 being the most amount,
respondents self-reported a 4.29 on the level of personal stigma related to maternal SUD
patients. This is less than the 5.06 reported before the educational resource. Respondents
reported a 3.79 on the level of treating maternal SUD patients differently compared to the
4.06 before the educational resource. The respondents also reported a 7.36 with 1 being
strongly disagreed and 10 strongly agreeing on the level of stigma being a health
determinant for people with maternal SUD compared to the 6.19 before the educational
resource. This is not a significant difference.
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Question Six: Does the healthcare provider plan to change his/her views of maternal
substance use disorder after the educational intervention?
This question was answered using questions 12 and 13 on the pre-test and
post-test (Figure 15). Both questions were answered using a 1-10 scale with 10 strongly
agreeing and 1 being strongly disagreed. The questions were identical on both the pre and
post-tests.
Figure 15
Self-reported plans to change views of maternal SUD
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Q12 I would like to be a role model for your colleagues.
Q13 I will make practice changes regarding Maternal SUD treatment.

Following the educational resource, there was a significant desire to be a role
model for colleagues (8.79/10 compared to 8.5/10) (r = .83, p = .000). However, there
was a slight decrease in the self-reporting of plans to make practice changes following the
educational resource (7.44/10 compared to 7.36/10) (r = .57, p = .022). This could be
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explained by the respondents having a high desire to change even before the educational
resource.
Question Seven: What are the healthcare providers’ intentions toward role
modeling regarding the treatment of maternal substance use disorder after the
educational intervention?
This question was answered using questions 11 and 12 on the pre-test and post-test
(Figure 16). Questions 11 and 12 were answered using a 1-10 scale with 10 strongly
agreeing and 1 being strongly disagreed. The questions were identical on both the pre and
post-tests.
Figure 16
Self-reported intentions toward role modeling

1 Strongly Disagree- 10 Strongly Agree

Pre-Test and Post-Test Questions 11 and 12
10

8

8.79

8.5

9

7.93
7.13

7
6
5

4
3
2
1
Q11

Q12
Pre-Test

Post-Test

LEGEND
Q11 I consider myself to be a role model for my colleagues.
Q12 I would like to be a role model for your colleagues.

Following the educational resource, there was an increase in self-reported role
models for colleagues (7.93/10 compared to 7.13/10) (r = .78, p = .000). There was also a
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self-reported increase in desire to become a role model regarding maternal SUD
following the educational resource (8.79/10 compared to 8.5/10).
Summary
The data revealed that by providing education on maternal SUD, stigma towards
maternal SUD patients reduces. Providers with the least amount of experience and
providers with over 10 years of experience reported the most amount of stigma.
Education should be focused on providers in school, right out of school, and again after
10 years of experience. Interestingly the level of stigma also increased if the provider had
a previous experience with a family or close friend with SUD. This could be due to a lack
of education and or treatment received by the family member or close friend with SUD.
The data also revealed that maternal healthcare providers only have a moderate
amount of knowledge related to maternal substance use disorder. However, they have a
strong desire to make practice change and become role models for their colleagues. The
data showed that providers are more likely to see the importance of and become role
models for maternal SUD patients after an educational intervention on maternal SUD.
Evidence-based research is readily available and should be encouraged and utilized by
providers.
By reducing the stigma related to maternal SUD and increasing the knowledge of
the disease, patients are more likely to be compliant with treatment plans and have
trusting relationships with their providers. Mothers are not only responsible for
themselves but also the vulnerable population of children under their care. By reducing
the stigma associated with maternal SUD, providers have an opportunity to make a
difference in the family dynamics, which may improve the odds of keeping families
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together, thereby reducing the risk for future generations of SUD patients and helping to
eliminate this epidemic.
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CHAPTER V

Discussion

The purpose of this study was to determine if an educational resource provided to
maternal healthcare providers would reduce the stigma associated with maternal SUD.
The secondary purpose of this study was to determine if years of experience and/or
previous experience with a family member or close friend with substance use disorder
(SUD) affected healthcare provider stigma. These questions were answered by
administering a pre-test, educational resource, and then a post-test. The data was then
used to answer the seven project questions.
Question One
Maternal SUD is a complex lifelong disease, with the provider being responsible
for not one but two lives. Adding to the complexity, the disease can also be co-occurring
with mental illness and/or trauma and non-compliance (Lee King et al., 2014). Education,
training, and role modeling are a must to keep up with this complex disease and treatment
plans. When providers are educated on the disease, they are more comfortable with
addressing the medical and physiologic aspects of the disease (Press et al., 2016).
Improved knowledge of maternal SUD was an expected outcome following the
educational resource.
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Maternal SUD knowledge was increased following the administration of the
educational resource. This was demonstrated by the higher self-reported scores of
knowledges of maternal SUD after the educational resource via the post-test. The seven
questions on the pre-test were compared to the post-test. After the educational resource
providers self-reported a higher level of knowledge on all seven knowledge-based
questions. Providers scored on average 1.02 points higher per question on the post-test
than on the pre-test.
Question Two
Stigma is a barrier to treatment in both maternal SUD and mental health disorders.
Cockroft et al. (2019) found an overall distrust of the healthcare system due to stigma.
Stigma can be found in many different forms including internal and external causes. It
was expected that the providers would score a moderate amount of stigma on the pre-test.
Self-reported stigma was recorded utilizing three questions. Providers scored on
average a 4.31 out of 10 on the stigma scale, with 10 being the most amount of stigma.
This was score was lower than expected and could be due to providers being unaware of
self-stigma prior to the stigma education.
Question Three
Long hours, limited breaks, and lack of vacation are causes for decreased provider
empathy (Moralle et al, 2016). This objective question was aimed at finding out if
providers' years of experience affected their level of stigma. It was hypothesized that the
more years of experience the provider had there would be an increase in their stigma.
Three self-reported stigma questions on the pre-test were compared to question
two in demographics. Providers scored on average two points higher on the stigma scale
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at the beginning of their career (less than 1 year) as well as after 10 years of experience.
This could be related to a lack of SUD education in medical and nursing training
programs and as hypothesized that the longer the provider serves, the more likely they
will have had a prior negative outcome with a SUD patient. This could also be due to the
importance of staying current on SUD developments and treatment plans.
Question Four
As stated previously, stigma can be from both internal and external factors. It was
hypothesized that provider stigma could be affected by their experience with a family
member or close friend with SUD. Stigma (related to treatment from providers) due to
their beliefs and bias from society was found to induce internal stigma from shame
(Howard, 2015). This internal stigma that providers have, that has nothing to do with the
patient in front of them, can then cause external stigma to the patient.
This question was answered using one question in demographics compared to
three questions on the pre-test. As expected, providers who reported not having a family
member or close friend with SUD scored on average 0.7 less on the stigma scale, when
compared to providers who reported having a family member or close friend with SUD.
This could be due to the relapsing and complexity of the disease as well as the chronic
nature of the disease (Pitt et al., 2018). SUD can leave friends and family members
feeling hopeless and helpless.
Question Five
Healthcare providers should be educated on the complexity of maternal SUD and
strategies to reduce the stigma (Howard, 2015). It is well known that evidence-based
treatment improves prevention, treatment, and recovery. Continued education is part of
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the required licensure of all maternal healthcare providers. When providers are educated
on the disease, they are more comfortable with addressing the medical and physiologic
aspects of the disease (Press et al., 2016). This question aimed at finding out what the
provider's level of stigma was after an educational resource.
The educational resource that was provided decreased the provider's self-reported
stigma. This was an expected finding. This question was determined by comparing the
self-reported scale of three questions on the pre-test (4.31) to the same three questions on
the post-test (3.57). The providers scored an average of 0.74 points less on the stigma
scale after viewing the educational resource provided. Although, that does not seem like a
big difference it did change the level of stigma from moderate to mild. This was also only
a brief two-page educational resource.
Question Six
The educational resource included information regarding the opportunity for
change during this major life event for maternal patients. Kotelcuch et al. (2017) found a
specific association between the treatment of SUD and a lower risk of adverse birth
outcomes. It was expected that the providers would be willing to make practice changes
following the educational resource.
This question was determined by comparing two questions on the pre-test to the
same questions on the post-test. Providers on average reported an increase of .29 on the
desire to become a role model for colleagues but had a 0.08 decrease on plans for practice
change following the educational recourse. This was not an expected outcome. This could
be due to the high levels of desire to be role models and make practice changes even
before the educational resource. It could also be due to, as stated previously, only being a
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small two-page electronic resource and not a larger simulated or public speaker
educational resource.
Question Seven
Previous studies have noted the lack of role models for maternal SUD providers.
Lack of provider role models has been determined to be a cause of reduced substance use
disorder treatment (Ober et al., 2017). This project aimed at increasing provider role
models by increasing knowledge and communication skills, thereby increasing provider
confidence and role models. Mora-Rios et al. (2017) reported on common practices of
lack of administrative support, including from the bureaucracy, as well as the stigma
received by coworkers for working with this population.
This question was determined by comparing the answers to two questions on the
pre-test to the same two questions on the post-test. The providers on average self-reported
an increased desire of 0.545 to become a role model and increased self-consideration as a
current role model following the educational resource. This was an expected finding. The
more the providers understood the disease process and the treatment of the disease, the
more likely they are to be confident providers and role models for their colleagues.
Observations
Registered nurses were the most likely to participate in this study. This could be
due to increased hours at the desk and the available time to participate in the study
(convenience). It could also be explained by the 12-hour shifts and the bond during the
laboring and delivering process that is formed between the nurse and the patient and the
desire for the nurse to help the patients. The physicians voiced an interest in the study and
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a need for change but were more reluctant to participate in the study and provide
feedback compared to the nurses.
Interestingly, those that reported having a prior experience with a family member
or close friend self-reported higher on the stigma scale. As stated previously, this could
be due to a negative outcome. With medical advances and increased evidence-based
treatment for this disease, this author hopes that this will change and those with prior
experiences can be role models for others, showing empathy and encouraging evidencebased treatment, and utilizing proper medical terminology in place of stigmatized terms.
The participates were able to take the pre-survey, review the educational resource,
and then take the post-survey. The study instruments utilized for this study worked as
expected. Displaying the responses to the pre-survey alongside the post-survey may assist
the participates in filling out the post-survey more accurately in future studies.
Participants reported increased knowledge and decreased stigma, but they could not recall
what number they reported on the pre-survey, so they were not sure what number to
report on the post-survey to reflect this improvement.
Overall, the participants self-reported an increased knowledge of maternal SUD
and a decrease in stigma following the educational resource. The outcomes of this study
were as expected. This can be utilized to encourage provider continued education on
SUD. A direct focus should be on providers at the beginning of their practice/career and
again after 10 years of service.
Provider role models are an integral part to combat this epidemic. As found in this
study, negative outcomes not only affect the patient and the family but can also affect the
provider. This can leave a lasting effect on the provider and how future patients are

53

approached. This shows the importance of utilizing evidence-based treatment to achieve
the best possible outcomes.
Evaluation of Theoretical Framework
“Modeling and Role Modeling" by Helen Erickson, Evelyn Tomlin, and Mary
Swain (as cited in Petiprin, 2016) was utilized by this research to gain a better
understanding of the lived experiences of patients with maternal SUD and how to better
assist them and providers with the treatment of the disease. This theory provided a
framework for educating providers from the patient’s viewpoint.
The results of this study support the use of the theory in educating providers on
the treatment of patients with maternal SUD. The self-reported results specifically point
to the need for additional education and role models for treating this population. The
theory aims at viewing patients from their point of view, which reduces stigma and
encourages individualization and collaboration at the same time. This aspect was used in
the development of the surveys and educational resources. Providers were asked to recall
personal experiences, evaluate personal stigmas and personal responsibilities to treat this
population. This theoretical framework aims for sustained long-term effects by
encouraging providers to act as role models. Long-term effects are listed but not
analyzed, due to time limitations.
Evaluation of Logic Model
The logic model for this study included short-term, intermediate, and long-term
outcomes. The results of the study indicate two out of four of the short-term outcomes
were met. This was an expected outcome of the study. The providers reported increased
knowledge of maternal SUD stigma and the increased self-awareness of needs, including
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role models and education. The other two short-term outcomes were not tested due to the
constraints of this study, including not utilizing patient medical records, and not
interviewing patients. The two short-term outcomes not tested were increased patient
compliance and increased patient-provider trust. According to previous studies when
provider stigma is reduced, patient compliance and trust will ensue.
One out of four of the intermediate and long-term outcomes were tested and
supported. With an increased awareness of the stigma associated with maternal SUD,
providers then self-reported reduced stigma and a desire to become a role model. The
other 3 intermediate and long-term outcomes were not tested due to HIPPA and the time
constraints of this study. Overall, the project results demonstrated a strong relationship
between the initial concepts and the logic model.
Limitations
There were several limitations to this study. The initial sample size was not as
large as expected. One of the three obstetrics and gynecology (OBGYN) providers
resigned just before the study leaving just two potential OBGYNs for the study.
The response size was smaller than expected. The organization in which the study
took place experienced a massive breach in their computer system which disabled the
organization's email for several months. This also occurred just before the study, making
it more difficult for potential participates to access their email, receive the invite, and
participate in the study.
This limitation was attempted to be overcome utilizing the new communication
system. The new system included the director sending out mass text messages. The
director sent the invite and instructions to the study via text. This could have led to
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participants sharing the link to the surveys outside of the intended sample, allowing those
that did not meet the inclusion and exclusion criteria to participate in the study.
The instruments utilized in this study had not been used and validated in previous
studies. This could have resulted in confusing survey questions, with unintentional selfreporting results. This could have affected the outcome of the results.
Implications for Future Projects and Research
Future study in this area is needed. A specific validated stigma scale could be
developed and utilized to evaluate providers' bias in areas of healthcare. This study could
be advanced by utilizing a larger sample size and printing the educational resource. As
stated previously, the post-survey questions could be set up displaying the participant's
pre-survey selection to report their self-reported gains or losses in particular areas more
accurately.
The design of the study could be accompanied by a presentation to better educate
providers, utilizing the educational resource as a reference to the presentation. The length
of the study could also be extended to facilitate increased participates. Continuation
Education Units (CEUs) could be awarded to increase participation.
Future studies are needed to report on the results of decreasing the stigma
associated with maternal SUD, including chart edits to follow patients’ compliance, drug
screens, and emergency room visits. Lengthier studies are needed to follow family
dynamics, children in state care, and access to community services. Lengthier studies are
needed to follow providers’ stigma based on past experiences, years of experience, and
work without time off.
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Implications for Practice/Health Policy/Education
This study included a small educational resource, a small sample size, and was
performed over a short length of time. However, the results of this study indicate a
significant need for additional education in this area. The participants indicated a high
desire to become role models and a lack of knowledge over the topic. Well-educated
providers demonstrate confidence in communicating, treating, and role modeling with
this population.
Policies should be directed at increasing continued education about SUD
specifically during the opioid epidemic, covid19 pandemic, and border crisis. Policies
should include reducing judicial involvement of maternal SUD and increasing mental
health services and treatment facilities in rural areas.
Providers should be encouraged to use evidence-based practice, including
screening for maternal SUD, using medically correct terms and nonpharmacologic pain
management, and supporting postpartum psychosocial support.
Conclusion
The stigma associated with maternal SUD is a determinate of healthcare. The goal
of this project was to determine if providing an educational resource to maternal
healthcare providers, would reduce the stigma associated with maternal SUD. This
project also aimed at increasing provider knowledge on the disease process of maternal
SUD and current treatment guidelines. Providers were given a pre-test, educational
resource, and post-test.
Overall, the project goals were met. Providers reported increased knowledge
following the educational resource and decreased self-reported stigma related to maternal
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SUD. Providers reported a desire to become role models and a need for increased
education on maternal SUD.
Although this study had several limitations, it proves the benefits of continued
education on maternal SUD. Previous studies have been done and evidence-based
treatment guidelines are available and should be utilized for the treatment of maternal
SUD. Continued studies are needed to assess the long-term benefits of reducing the
stigma associated with this population. Predicted long-term benefits include increased
patient compliance, increased patient-provider trust, decreased late prenatal care,
decreased neonatal abstinence syndrome, and finally decreased children in state care and
increased family dynamics.
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APPENDIX

Appendix A
Reducing the Stigma Associated with Maternal Substance Use Disorder
In A Rural Midwest Hospital and Clinic
Pre-Test Survey
Demographics
1. What is your role in healthcare?
A. OBGYN
B. Family Practice Physician
C. Registered or Licensed Nurse
D. Pediatrician
E. Nurse Practitioner
F. Nurse Midwife
G. Would Rather Not Say
2. How many years have you been in this role?
A. 0-1 year
B. 2-5 years
C. 6-10 years
D. 10+ years
E. Would Rather Not Say
3. Do you have a family member or close friend with Substance Use Disorder?
A. Yes
B. No
C. Would Rather Not Say
Provider Awareness Associated with Maternal Substance Use Disorder
On a scale of 1-10, with 1 being the least amount and 10 being the most, please rate the
following:
1. How much do you know about Maternal Substance Use Disorder?
1

2

3

4

5

6

7

8

9

10

2. How much do you know about the perceived stigma associated with Maternal
Substance Use Disorder?
1

2

3

4

5

6
68

7

8

9

10

3. How would you rate your level of confidence in communicating with people with
Substance Use Disorder?
1

2

3

4

5

6

7

8

9

10

4. How important are role models to patients with Maternal Substance Use
Disorder?
1

2

3

4

5

6

7

8

9

10

Please rate how strongly you agree or disagree with the following statements, with 1
being strongly disagreeing and 10 strongly agreeing.
5. Those with Substance Use Disorder are to blame for the problem.
1

2

3

4

5

6

7

8

9

10

6. Those with Substance Use Disorder are responsible for their own health.
1

2

3

4

5

6

7

8

9

10

9

10

7. Substance Use Disorder is a treatable chronic disease.
1

2

3

4

5

6

7

8

Self-Perceived Stigma Scale
On a scale of 1-10, with 1 being the least amount and 10 being the most, please rate the
following:
8. How would you rate your personal stigma related to Maternal Substance Use
Disorder patients?
1

2

3

4

5

6

7

8

9

10

9. Do you feel you treat Maternal Substance Use Disorder patients differently?
1

2

3

4

5

6

7

8

9

10

Please rate how strongly you agree or disagree with the following statements, with 1
being strongly disagreeing and 10 strongly agreeing.
10. Stigma is a health determinant for people with Maternal Substance Use Disorder.
1

2

3

4

5

6

69

7

8

9

10

Clinical Practice
Please rate how strongly you agree or disagree with the following statements, with 1
being strongly disagreeing and 10 strongly agreeing.
11. I consider myself to be a role model for my colleagues.
1

2

3

4

5

6

7

8

9

10

8

9

10

12. I would like to be a role model for your colleagues.
1

2

3

4

5

6

7

13. I will make practice changes regarding Maternal SUD treatment.
1

2

3

4

5

6

7

8

9

10

14. Please write any other questions, concerns, or comments you may have regarding
your current practice and/or Maternal Substance Use Disorder treatment.
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Appendix B
Reducing the Stigma Associated with Maternal Substance Use Disorder
In A Rural Midwest Hospital and Clinic
Post-Test Survey
Provider Awareness Associated with Maternal Substance Use Disorder
On a scale of 1-10, with 1 being the least amount and 10 being the most, please rate the
following:
1. How much do you know about Maternal Substance Use Disorder?
1
2
3
4
5
6
7
8
9
10
2. How much do you know about the perceived stigma associated with Maternal
Substance Use Disorder?
1
2
3
4
5
6
7
8
9
10
3. How would you rate your level of confidence in communicating with people with
Substance Use Disorder?
1
2
3
4
5
6
7
8
9
10
4. How important are role models to patients with Maternal Substance Use
Disorder?
1

2

3

4

5

6

7

8

9

10

Please rate how strongly you agree or disagree with the following statements, with 1
being strongly disagreeing and 10 strongly agreeing.
5. Those with Substance Use Disorder are to blame for the problem.
1

2

3

4

5

6

7

8

9

10

6. Those with Substance Use Disorder are responsible for their own health.
1

2

3

4

5

6

7

8

9

10

9

10

7. Substance Use Disorder is a treatable chronic disease.
1

2

3

4

5

6
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7

8

Self-Perceived Stigma Scale
8. On a scale of 1-10, with 1 being the least amount and 10 being the most amount,
please rate the following: How would you rate your personal stigma related to
Maternal Substance Use Disorder patients?
1
2
3
4
5
6
7
8
9
10
9. Do you feel you treat Maternal Substance Use Disorder patients differently?
1

2

3

4

5

6

7

8

9

10

Please rate how strongly you agree or disagree with the following statements. With 1
being strongly disagreeing and 10 strongly agreeing.
10. Stigma is a health determinant for people with Maternal Substance Use Disorder.
1

2

3

4

5

6

7

8

9

10

Clinical Practice
Please rate how strongly you agree or disagree with the following statements. With 1
being strongly disagreeing and 10 strongly agreeing.
11. I consider myself to be a role model for my colleagues.
1

2

3

4

5

6

7

8

9

10

8

9

10

12. I would like to be a role model for your colleagues.
1

2

3

4

5

6

7

13. I will make practice changes regarding Maternal SUD treatment.
1

2

3

4

5

6

7

8

9

10

14. Please write any other questions, concerns, or comments you may have regarding
your current practice and/or Maternal Substance Use Disorder treatment.
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Appendix C
Educational Resource
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Appendix D
CRMC Letter of Cooperation
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Appendix E
IRB Forms
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